UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Function, structure and therapeutic potential of complement C5a receptors

British journal of pharmacology, 2007-10, Vol.152 (4), p.429-448

2007

Volltextzugriff (PDF)

Biased signalling and proteinase‐activated receptors (PARs): targeting inflammatory disease

British journal of pharmacology, 2014-03, Vol.171 (5), p.1180-1194

2014

Volltextzugriff (PDF)

Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110)

British journal of pharmacology, 2012-03, Vol.165 (5), p.1413-1423

2012

Volltextzugriff (PDF)

Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches

Advanced drug delivery reviews, 2020, Vol.157, p.2-36

2020

Volltextzugriff (PDF)

Protease Inhibitors: Current Status and Future Prospects

Journal of medicinal chemistry, 2000-02, Vol.43 (3), p.305-341

2000

Volltextzugriff (PDF)

Potent Antimalarial Activity of Histone Deacetylase Inhibitor Analogues

Antimicrobial Agents and Chemotherapy, 2008-04, Vol.52 (4), p.1454-1461

2008

Volltextzugriff (PDF)

Histone deacetylase inhibitors and periodontal bone loss

Journal of periodontal research, 2011-12, Vol.46 (6), p.697-703

2011

Volltextzugriff (PDF)

West Nile Virus NS2B/NS3 protease as an antiviral target

Current medicinal chemistry, 2008-11, Vol.15 (27), p.2771-2784

2008

Volltextzugriff (PDF)

Antagonism of the proinflammatory and pronociceptive actions of canonical and biased agonists of protease‐activated receptor‐2

British journal of pharmacology, 2016-09, Vol.173 (18), p.2752-2765

2016

Volltextzugriff (PDF)

New insights into growth hormone action

Journal of molecular endocrinology, 2006-02, Vol.36 (1), p.1-7

2006

Volltextzugriff (PDF)

Pathway‐selective antagonism of proteinase activated receptor 2

British journal of pharmacology, 2014-09, Vol.171 (17), p.4112-4124

2014

Volltextzugriff (PDF)

Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals

Mucosal immunology, 2017-01, Vol.10 (1), p.58-68

2017

Volltextzugriff (PDF)

Mapping transmembrane residues of proteinase activated receptor 2 (PAR2) that influence ligand-modulated calcium signaling

Pharmacological research, 2017-03, Vol.117, p.328-342

2017

Volltextzugriff (PDF)

Differential Anti-inflammatory Activity of HDAC Inhibitors in Human Macrophages and Rat Arthritis

The Journal of pharmacology and experimental therapeutics, 2016-02, Vol.356 (2), p.387-396

2016

Volltextzugriff (PDF)

Histone deacetylases (HDAC) in physiological and pathological bone remodelling

Bone (New York, N.Y.), 2017-02, Vol.95, p.162-174

2017

Volltextzugriff (PDF)

Macrocycles mimic the extended peptide conformation recognized by aspartic, serine, cysteine and metallo proteases

Current medicinal chemistry, 2001-07, Vol.8 (8), p.893-907

2001

Volltextzugriff (PDF)

Low-Molecular-Weight Peptidic and Cyclic Antagonists of the Receptor for the Complement Factor C5a

Journal of medicinal chemistry, 1999-06, Vol.42 (11), p.1965-1974

1999

Volltextzugriff (PDF)

The use of live-animal micro-computed tomography to determine the effect of a novel phospholipase A2 inhibitor on alveolar bone loss in an in vivo mouse model of periodontitis

Journal of periodontal research, 2009-06, Vol.44 (3), p.317-322

2009

Volltextzugriff (PDF)

Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate

British Journal of Cancer, 1999-06, Vol.80 (8), p.1252-1258

1999

Volltextzugriff (PDF)

Inhibitors of histone deacetylases in class I and class II suppress human osteoclasts in vitro

Journal of cellular physiology, 2011-12, Vol.226 (12), p.3233-3241

2011

Volltextzugriff (PDF)

Is Oxidative Damage by β-Amyloid and Prion Peptides Mediated by Hydrogen Atom Transfer from Glycine α-Carbon to Methionine Sulfur within β-Sheets?

Journal of the American Chemical Society, 2000-10, Vol.122 (40), p.9761-9767

2000

Volltextzugriff (PDF)

Conformational Selection of Inhibitors and Substrates by Proteolytic Enzymes: Implications for Drug Design and Polypeptide Processing

Journal of medicinal chemistry, 2000-04, Vol.43 (7), p.1271-1281

2000

Volltextzugriff (PDF)

Macrocyclic Peptidomimetics Forcing Peptides into Bioactive Conformations

Current medicinal chemistry, 1995-08, Vol.2 (2), p.654-686

1995

Volltextzugriff (PDF)

Towards protein surface mimetics

Current medicinal chemistry, 1998-02, Vol.5 (1), p.29-62

1998

Volltextzugriff (PDF)

Anti-malarial effect of histone deacetylation inhibitors and mammalian tumour cytodifferentiating agents

International journal for parasitology, 2000-05, Vol.30 (6), p.761-768

2000

Volltextzugriff (PDF)

1 – 25 von 386

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(357)
Mit Volltextzugriff
(341)

Publikationsform

Sprache

Englisch
(385)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Function, structure and therapeutic potential of complement C5a receptors

Biased signalling and proteinase‐activated receptors (PARs): targeting inflammatory disease

Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110)

Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches

Protease Inhibitors: Current Status and Future Prospects

Potent Antimalarial Activity of Histone Deacetylase Inhibitor Analogues

Histone deacetylase inhibitors and periodontal bone loss

West Nile Virus NS2B/NS3 protease as an antiviral target

Antagonism of the proinflammatory and pronociceptive actions of canonical and biased agonists of protease‐activated receptor‐2

New insights into growth hormone action

Pathway‐selective antagonism of proteinase activated receptor 2

Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals

Mapping transmembrane residues of proteinase activated receptor 2 (PAR2) that influence ligand-modulated calcium signaling

Differential Anti-inflammatory Activity of HDAC Inhibitors in Human Macrophages and Rat Arthritis

Histone deacetylases (HDAC) in physiological and pathological bone remodelling

Macrocycles mimic the extended peptide conformation recognized by aspartic, serine, cysteine and metallo proteases

Low-Molecular-Weight Peptidic and Cyclic Antagonists of the Receptor for the Complement Factor C5a

The use of live-animal micro-computed tomography to determine the effect of a novel phospholipase A2 inhibitor on alveolar bone loss in an in vivo mouse model of periodontitis

Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate

Inhibitors of histone deacetylases in class I and class II suppress human osteoclasts in vitro

Is Oxidative Damage by β-Amyloid and Prion Peptides Mediated by Hydrogen Atom Transfer from Glycine α-Carbon to Methionine Sulfur within β-Sheets?

Conformational Selection of Inhibitors and Substrates by Proteolytic Enzymes: Implications for Drug Design and Polypeptide Processing

Macrocyclic Peptidomimetics Forcing Peptides into Bioactive Conformations

Towards protein surface mimetics

Anti-malarial effect of histone deacetylation inhibitors and mammalian tumour cytodifferentiating agents

Suchergebnisse filtern